找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Keratoprostheses and Artificial Corneas; Fundamentals and Sur M. Soledad Cortina,Jose de la Cruz Book 2015 Springer-Verlag Berlin Heidelber

[復制鏈接]
樓主: 銀河
11#
發(fā)表于 2025-3-23 13:18:11 | 只看該作者
Management of Glaucoma Associated with Boston KPro Type I Implantationsurgery and is associated with poorer postoperative outcomes. Pathophysiologic factors include underlying disease process, synechial angle closure, steroid-response intraocular pressure (IOP) elevation, and possible pupillary block. Frequent monitoring with structural and functional testing measures
12#
發(fā)表于 2025-3-23 14:06:27 | 只看該作者
Boston KPro Type 1: The Role of the Contact Lensafter surgery is a Kontur? Precision Sphere with a 16.0 mm diameter, 9.8 mm base curve, and plano power. Proper centration of the lens and complete corneal coverage are essential for a proper fit, lens retention, and ocular protection. Over-refraction should be measured at each visit and power chang
13#
發(fā)表于 2025-3-23 21:20:18 | 只看該作者
Boston KPro Type I: Vitreoretinal Considerations. As the use of KPro increases dramatically, so too does the frequency of posterior segment complications seen by the vitreoretinal surgeon in this patient population, as well as the importance of addressing them expeditiously. Special consideration in diagnostic imaging and surgical planning is req
14#
發(fā)表于 2025-3-24 02:02:54 | 只看該作者
15#
發(fā)表于 2025-3-24 03:35:37 | 只看該作者
Keratoprostheses in the Setting of Autoimmune Disorderstions including keratoprostheses. The most challenging of this subset of patients to treat are those with corneal blindness due to autoimmune diseases. Studies have suggested that these patients respond poorly to transplantation due to alterations in corneal tissue at the level of the cellular, micr
16#
發(fā)表于 2025-3-24 08:56:46 | 只看該作者
17#
發(fā)表于 2025-3-24 13:07:43 | 只看該作者
José L. Güell MD, PhD,Elena Arrondo,M. Soledad Cortina MD,Jaime Echevarría,Maria V. Gómez-Resa,Oscarular. We establish the correspondence between evidence-based health care and translational effectiveness, which, as defined by AHRQ, represents the utilization of the best available evidence in clinical settings. We discuss the process of evidence-based health care and translational effectiveness in
18#
發(fā)表于 2025-3-24 17:11:33 | 只看該作者
Ahmad A. Aref MD,Thasarat S. Vajaranant MDcondition (diagnosis) (.., prevalence, sensitivity, specificity) or from monitoring its course (i.e., prognosis) (.., prevalence and relative prevalence in cross-sectional observation studies, incidence in cohort studies, and experimental designs including clinical trials). The process of quantifica
19#
發(fā)表于 2025-3-24 21:58:55 | 只看該作者
20#
發(fā)表于 2025-3-24 23:38:10 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學 Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點評 投稿經(jīng)驗總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學 Yale Uni. Stanford Uni.
QQ|Archiver|手機版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-7 16:15
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復 返回頂部 返回列表
阿拉善盟| 邳州市| 博乐市| 左贡县| 兰考县| 陵川县| 普洱| 上蔡县| 临颍县| 阿合奇县| 华阴市| 清新县| 大化| 梧州市| 涿州市| 雷山县| 资源县| 东丽区| 永丰县| 阿克苏市| 蕉岭县| 石泉县| 武清区| 泰宁县| 梧州市| 崇左市| 镇安县| 青河县| 监利县| 防城港市| 宁河县| 延寿县| 怀集县| 泾源县| 葫芦岛市| 犍为县| 兴义市| 永仁县| 剑河县| 山东省| 东莞市|